Diverse effects of coexpression of human SOD1 variants on motor neuron disease
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Eiichi Tokuda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biosciences, Umeå University, Umeå, SE 901 85, Sweden. Hauptthemen laut MEDLINE: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Superoxide Dismutase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Västerbotten County Council, Torsten and Ragnar Söderberg Foundation, Umeå University Insamlingsstiftelsen, Knut and Alice Wallenberg Foundation.
Abstract (Originalsprache)
Mutations in superoxide dismutase-1 (SOD1) are a common cause of amyotrophic lateral sclerosis (ALS). Inheritance is as a rule dominant, but in carriers of the most common mutation, D90A, disease can develop in both homozygous and, more rarely, in heterozygous individuals with unexplained differences in clinical presentation. There is mounting evidence that prion-like spread of SOD1 aggregation is the primary cause of the disease. Two different strains of aggregates have been found to arise in human SOD1 (hSOD1) transgenic mouse models of ALS. Strain A is formed by most mutants including hSOD1G85R and hSOD1WT, whereas hSOD1D90A transgenic mice form a distinct strain B in addition to A. To explore the effects of aggregate strain propensities when hSOD1 variants are coexpressed, we generated digenic hSOD1G85R/WT and hSOD1G85R/D90A mice. Coexpression of hSOD1WT considerably shortened the lifespan of hSOD1G85R mice to the extent expected from the neurotoxicities of the variants alone. In contrast, coexpression of hSOD1D90A had a minimal effect on survival, far smaller than expected. Moreover, time from onset to the end stage was markedly prolonged in the hSOD1G85R/D90A mice. Aggregation of hSOD1 developed concomitantly with motor neuron disease, and the aggregates contained large amounts of both coexpressed variants in both digenic models. Our findings suggest that hSOD1WT has high a capacity to coaggregate with mutants and enhance neurotoxicity. Such interactions may be restricted by differences in strain propensities, which may contribute to the primarily recessive inheritance associated with the hSOD1D90A mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biosciences, Umeå University, Umeå, SE 901 85, Sweden.
- Laboratory of Clinical Medicine, School of Pharmacy, Nihon University, 7-7-1, Narashinodai, Funabashi, Chiba 274-8555, Japan.
- Department of Clinical Science, Neurosciences, Umeå University, Umeå, SE 901 85, Sweden.
ORCID-Profile: Eiichi Tokuda, Laura Leykam, Per Zetterström, Thomas Brännström, Peter M Andersen, Stefan L Marklund
Förderung
- Västerbotten County Council
- Torsten and Ragnar Söderberg Foundation, Umeå University Insamlingsstiftelsen
- Knut and Alice Wallenberg Foundation
- Swedish Research Council
- Swedish Brain Foundation
Zitieren
APA
Tokuda, E., Leykam, L., Zetterström, P., Brännström, T., Andersen, P. M., & Marklund, S. L. (2025). Diverse effects of coexpression of human SOD1 variants on motor neuron disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf088
Vancouver
Tokuda E, Leykam L, Zetterström P, Brännström T, Andersen PM, Marklund SL. Diverse effects of coexpression of human SOD1 variants on motor neuron disease. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf088
BibTeX
@article{Tokuda2025,
author = {Tokuda, Eiichi and Leykam, Laura and Zetterström, Per and Brännström, Thomas and Andersen, Peter M and Marklund, Stefan L},
title = {Diverse effects of coexpression of human SOD1 variants on motor neuron disease},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf088}
}
EUVIMED